Abstract
Signal transduction systems are known to widely regulate complex biological events such as cell proliferation and differentiation. Although numerous biological analyses have revealed many of the key molecules and events involved in cell signaling, an integrative view of this complicated system cannot provide a fundamental theory on the regulation of the entire network without analyzing the dynamic behavior of these molecules and events at the system level. Recent technological advances in mass spectrometry-based proteomics and bioinformatics have enabled us to obtain a networkwide description of signaling dynamics through the large-scale identification and quantification of phosphorylated molecules. Accordingly, computational modeling on the basis of dynamic proteomics data has also been applied to the network analysis of representative signaling systems such as the epidermal growth factor receptor pathway. This review focuses on the current status of quantitative proteomics technology for temporal studies of signal transduction and on the application of comprehensive signaling dynamics data to mathematical analyses of regulatory networks. The perspective on proteomics data-driven systems biology is also discussed.
Keywords: Signal transduction, quantitative proteomics, systems biology, LC-MS/MS, computational modeling
Current Bioinformatics
Title: Comprehensive Description of Signal Transduction Networks by Quantitative Proteomics and Systems Biology
Volume: 4 Issue: 2
Author(s): Masaaki Oyama
Affiliation:
Keywords: Signal transduction, quantitative proteomics, systems biology, LC-MS/MS, computational modeling
Abstract: Signal transduction systems are known to widely regulate complex biological events such as cell proliferation and differentiation. Although numerous biological analyses have revealed many of the key molecules and events involved in cell signaling, an integrative view of this complicated system cannot provide a fundamental theory on the regulation of the entire network without analyzing the dynamic behavior of these molecules and events at the system level. Recent technological advances in mass spectrometry-based proteomics and bioinformatics have enabled us to obtain a networkwide description of signaling dynamics through the large-scale identification and quantification of phosphorylated molecules. Accordingly, computational modeling on the basis of dynamic proteomics data has also been applied to the network analysis of representative signaling systems such as the epidermal growth factor receptor pathway. This review focuses on the current status of quantitative proteomics technology for temporal studies of signal transduction and on the application of comprehensive signaling dynamics data to mathematical analyses of regulatory networks. The perspective on proteomics data-driven systems biology is also discussed.
Export Options
About this article
Cite this article as:
Oyama Masaaki, Comprehensive Description of Signal Transduction Networks by Quantitative Proteomics and Systems Biology, Current Bioinformatics 2009; 4 (2) . https://dx.doi.org/10.2174/157489309788184738
DOI https://dx.doi.org/10.2174/157489309788184738 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Ultrasound Assisted Synthesis of 2-alkynyl Pyrazolo[1,5-a]pyrimidines as Potential Anti-cancer Agents
Letters in Drug Design & Discovery Application of Liposomes in Cancer Therapy: An Assessment of the Advancement of Technology Through Patent Documents
Recent Patents on Nanotechnology Ultrasound Image Based Tumor Classification via Deep Polynomial Network and Multiple Kernel Learning
Current Medical Imaging Non-canonical Molecular Targets for Novel Analgesics: Intracellular Calcium and HCN Channels
Current Neuropharmacology Integrating the Universe of Effector and Regulatory Immune Cell Subsets: An Emerging Role of Protein-Glycan Interactions
Current Immunology Reviews (Discontinued) Molecular Interplay between Platelets and the Vascular Wall in Thrombosis and Hemostasis
Current Vascular Pharmacology Exploration of (hetero)aryl Derived Thienylchalcones for Antiviral and Anticancer Activities
Medicinal Chemistry Microbial Antigenic Pressure and Evolution of the Immune Response: Toward a Better Understanding of the Human Immune System in Health and Disease and Therapeutic Interventions
Endocrine, Metabolic & Immune Disorders - Drug Targets Resveratrol and Its Analogs As Antitumoral Agents For Breast Cancer Treatment
Mini-Reviews in Medicinal Chemistry Strategies for the Biological Evaluation of Gold Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Nanotechnology Platforms; An Innovative Approach to Brain Tumor Therapy
Medicinal Chemistry Lipid-Based Drug Delivery Systems for Cancer Treatment
Current Drug Targets Preparation and Characterization of a Heterogeneous Catalyst from Water Hyacinth (Eichhornia crassipes): Catalytic Application in the Synthesis of bis(indolyl)methanes and bis(pyrrolyl) methanes Under Solvent Free Condition
Current Catalysis Oncogenic Properties of HIV-Tat in Colorectal Cancer Cells
Current HIV Research 1, 3, 6-Trihydroxy-7-Methyl-9, 10-Anthracenedione Isolated from genus Lindera with Anti-Cancer Activity
Anti-Cancer Agents in Medicinal Chemistry Development of a Sensitive Cost-Effective Capture ELISA for Detection of Murine Monoclonal Antibodies - Correlation with SPR Biosensor Technology
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Biologic Therapies in Primary Sjögren's Syndrome
Current Pharmaceutical Biotechnology Multiple Sclerosis: Pathogenesis and Treatment
Current Neuropharmacology Strategies to Increase the Oral Bioavailability of Nucleoside Analogs
Current Medicinal Chemistry Preface (Hot Topic: New Frontiers and ”Pitfalls“ in Cytokine and Anti-cytokine Therapies Executive Editor: Atsushi Oda)
Current Pharmaceutical Design